Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
XW-004 by Sciwind Biosciences for Obesity: Likelihood of Approval
XW-004 is under clinical development by Sciwind Biosciences and currently in Phase I for Obesity. According to GlobalData, Phase I...
Data Insights
XW-004 by Sciwind Biosciences for Type 2 Diabetes: Likelihood of Approval
XW-004 is under clinical development by Sciwind Biosciences and currently in Phase I for Type 2 Diabetes. According to GlobalData,...